Evidence map›Paper›PMID 32705456›Full record

ArticleJournal of neuro-oncology2020

Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas.

Caroline Apra, Paul Roblot, Abdu Alkhayri, Caroline Le Guérinel, Marc Polivka, Dorian Chauvet

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Hormone therapies in meningioma-where are we?Journal of neuro-oncology · 2023
    Review
  12. Article
  13. Article
  14. Association of Hormonal Contraception with Meningioma Location in Indonesian Patients.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Caroline ApraNeurosurgery Department, Hôpital Pitié Salpêtrière, 43-87 bd de l'Hôpital, 75013, Paris, France. caroline.apra@neurochirurgie.fr.ORCID http://orcid.org/0000-0003-0944-9544
Paul RoblotNeurosurgery Department, Centre Hospitalo-Universitaire, Bordeaux, France.
Abdu AlkhayriNeurosurgery Department, Hôpital Fondation Adolphe de Rothschild, Paris, France.
Caroline Le GuérinelNeurosurgery Department, Hôpital Fondation Adolphe de Rothschild, Paris, France.
Marc PolivkaPathology Department, Hôpital Lariboisière, Paris, France.
Dorian ChauvetNeurosurgery Department, Hôpital Fondation Adolphe de Rothschild, Paris, France.
Fondation Ophtalmologique Adolphe de Rothschild · FRHôpital Lariboisière · FRSorbonne Université · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe great heterogeneity of meningiomas is challenging and we need to distinguish relevant subgroups. Spheno-orbital osteomeningiomas (SOOM) constitute a clinically specific entity, with slow-growing benign osteo-meningiomatous tumors, which recur after surgery in one fourth of cases. Neurosurgical daily practice, supported by the literature, shows that the vast majority of patients with SOOM are women, and we explored whether their epidemiological and hormonal profiles suggest a progesterone influence.

methodsWe retrospectively documented all radiologically and histologically confirmed cases of SOOM operated in 2005-2019 in our institution. We completed the clinical and hormone history by systematic telephone interviews.

resultsIn the literature, SOOM occur significantly more often in women than other meningiomas (749/847, 86.4% versus 73.8%, p = 0.002). Among 175 cases, we included 124 patients, 93.5% were women, younger than men (51 ± 5 versus 63 ± 8, p = 0.02). Women' meningiomas showed more progesterone receptors (96.4% versus 50%, p < 0.001). Exogenous hormonal intake, reliable in 82 cases, concerned 83.3% (64/78) of women, with frequent progesterone intake: 13 oestroprogestogenic treatment only, with old-generation progesterone analogs, 41 progesterone analogs (cyproterone acetate, nomegestrol acetate, chlormadinone, promegestone, etonogestrel, levonogestrel), 7 substitutive hormonal therapy for menopause, 3 others. Duration of treatment was 2-40 years, median 10 years.

conclusionsSOOM develop preferentially in women in their fifties, who often received progesterone analogs, and show progesterone receptors. Progesterone analogs are incriminated in skull base meningiomas, and this is the first report on the prevalence of exogenous hormone therapy specifically in SOOM. Whether SOOM reduce after treatment discontinuation, in particular the osteoma part, needs to be explored. Anti-progesterone treatments may represent an avenue for future research in soom.

Indexed as

AdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMeningeal NeoplasmsMeningiomaMiddle AgedOrbital DiseasesProgesteroneProgestinsPrognosisRetrospective StudiesRisk FactorsProgesteroneProgestinsCyproterone acetateNomegestrol acetateOsteomeningiomaProgestinSkull base meningiomaSphenoorbital meningioma

Identifiers

PMID32705456
OpenAlexW3044141204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.